A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2011
08/25/2011	US20110207754 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
08/25/2011	US20110207746 New compounds i
08/25/2011	US20110207734 Azine Derivatives and Methods of Use Thereof
08/25/2011	US20110207732 Azaindole derivatives
08/25/2011	US20110207730 Ion channel modulating compounds and uses thereof
08/25/2011	US20110207724 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anit-hypertensive compounds
08/25/2011	US20110207720 Quinolin-4-one and 4-oxodihyrdocinnoline derivatives as inhibitors of poly(adp-ribose) polymerase (parp)
08/25/2011	US20110207717 2-aminopyrimidine compounds as serotonin receptor modulators
08/25/2011	US20110207714 Serotonin receptor modulators
08/25/2011	US20110207713 PYRIDO[3,2-d]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE
08/25/2011	US20110207709 Modulators of serotonin receptor
08/25/2011	US20110207703 Oxidized lipid compounds and uses thereof
08/25/2011	US20110207679 Methods of treatment using il-16 antagonist peptides
08/25/2011	US20110207678 Cd44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
08/25/2011	US20110207677 Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Chronic or Non-Chronic Inflammatory Digestive Diseases
08/25/2011	US20110207664 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins
08/25/2011	US20110207658 High Purity Lipopeptides
08/25/2011	US20110207656 MUC1, CASPASE-8, and DED-CONTAINING PROTEINS
08/25/2011	US20110206786 Acai and Iridoid Based Formulations
08/25/2011	US20110206762 Oral pharmaceutical formulation of pelubiprofen with improved dissolution rate and stability
08/25/2011	US20110206760 Angiopoietin derived peptides
08/25/2011	US20110206755 Methods and products for manipulating uncoupling protein expression
08/25/2011	US20110206754 Implant device
08/25/2011	US20110206752 Compositions for the treatment of pain and/or inflamation
08/25/2011	US20110206721 Fermented soy nutritional supplements including mushroom components
08/25/2011	US20110206720 Anti-inflammatory usage of antrodia cinnamomea fruit body derivatives
08/25/2011	US20110206687 Isolation And Purification Of Anti-IL-13 Antibodies Using Protein A Affinity Chromatography
08/25/2011	US20110206686 Il-23 antibodies
08/25/2011	US20110206682 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
08/25/2011	US20110206669 Mcp1 fusions
08/25/2011	US20110206668 Methods and compositions for modulating immunity
08/25/2011	US20110206664 Therapeutic agent for chronic arthritides diseases of childhood-related diseases
08/25/2011	US20110206653 Tetrazole compounds for reducing uric acid
08/25/2011	US20110206613 METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT
08/25/2011	US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues
08/25/2011	US20110206607 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
08/25/2011	DE102011009719A1 Agent useful e.g. for treating neurodermitis and diabetes mellitus comprises a fat phase including tocotrienols with lipids e.g. gamma -linolenic acid and an aqueous phase comprising e.g. palm fruit water, vitamin C, vitamin B2 and
08/25/2011	CA2827694A1 Cyclic tetrapeptides and therapeutic applications thereof
08/25/2011	CA2790176A1 Triazolo [4, 5 - b] pyridin derivatives
08/25/2011	CA2790070A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
08/25/2011	CA2789711A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
08/24/2011	EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof
08/24/2011	EP2360185A2 Administration of agents for the treatment of inflammation
08/24/2011	EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using
08/24/2011	EP2359855A2 Methods of administering anti-TNFalpha antibodies
08/24/2011	EP2359849A1 Combination therapy
08/24/2011	EP2359842A1 Netrin-related compositions and uses
08/24/2011	EP2359831A2 Therapeutic applications of pro-apoptotic benzodiazepines
08/24/2011	EP2358725A1 Imidazolothiazole compounds as modulators of protein kinase
08/24/2011	EP2358704A1 7-azaspiro [3.5]nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase
08/24/2011	EP2358692A1 Cysteine protease inhibitors
08/24/2011	EP2358681A1 Substituted 4-(1,2,3,4-tetrahydroisochinolin-2-yl)-4-oxo-butyric acid amide as kcnq2/2 modulators
08/24/2011	EP2358378A2 Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
08/24/2011	EP2358370A2 Treatment of proteinopathies using a farnesyl transferase inhibitor
08/24/2011	EP1940818B1 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors
08/24/2011	EP1856155B1 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
08/24/2011	EP1583737B1 Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) ester
08/24/2011	EP1499729B1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
08/24/2011	EP1485353B1 New inhibitors of histone deacetylase
08/24/2011	EP1480962B1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
08/24/2011	EP1480603B1 Use of sugar esters in cosmetic preparations
08/24/2011	EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases
08/24/2011	EP1259544B1 Heterologous polypeptide of the tnf family
08/24/2011	EP0754059B2 Methods and compositions useful for inhibition of angiogenesis
08/24/2011	CN201938881U 坐垫 Cushion
08/24/2011	CN102164924A 3H-imidaz0 [4, 5-B] pyridine- 6 -carboxamides as anti -inflammatory agents
08/24/2011	CN102164922A 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti -inflammatory agents
08/24/2011	CN102164920A Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof as FAAH enzyme inhibitor
08/24/2011	CN102164917A Compounds which selectively modulate the CB2 receptor
08/24/2011	CN102164916A Compounds which selectively modulate the CB2 receptor
08/24/2011	CN102164911A 1H-benzimidazole-5-carboxamides as anti-inflammatory agents
08/24/2011	CN102164904A 6-substituted isoflavonoid compounds and uses thereof
08/24/2011	CN102164902A 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
08/24/2011	CN102164888A Deacetylase inhibitors and uses thereof
08/24/2011	CN102164887A Halogenated analogues of anti-fibrotic agents
08/24/2011	CN102164610A Compositions for the treatment of pain and/or inflamation
08/24/2011	CN102164603A Methods and kits for treating cluster headache disorders
08/24/2011	CN102164596A Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
08/24/2011	CN102161653A Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof
08/24/2011	CN102160890A Pharmaceutical composition comprising an analgesic peptide
08/24/2011	CN102160883A Method for preparing medicine for treating sprain and contusion
08/24/2011	CN102160880A Transdermal bone warming liquor
08/24/2011	CN102160873A Method for preparing total polygala xanthone
08/24/2011	CN102160861A Infusion medicament analgesic patch
08/24/2011	CN102160855A Dex-ibuprofen sustained release tablets and preparation method thereof
08/24/2011	CN102160852A Ibuprofen injection and preparation method thereof
08/24/2011	CN102160851A Ibuprofen injection and preparation method thereof
08/24/2011	CN102160731A Health care pillow prepared from traditional Chinese medicine and preparation method and applications thereof
08/24/2011	CN101816718B Method for producing traditional Chinese medicine composition for treating lumbocrural pain by utilizing micro-powder technology
08/24/2011	CN101810766B Chinese medicinal composition and preparation method and application thereof
08/24/2011	CN101693022B Method for preparing resveratrol sustained-release capsule capable of preventing rheumatoid arthritis
08/24/2011	CN101670068B Medicament for treating gonarthromeningitis and preparation technology thereof
08/24/2011	CN101642433B Nimesulide liposome solid preparation and preparation method of drug composite thereof
08/24/2011	CN101543623B Green healthy bone-strengthening capsule
08/24/2011	CN101530470B Medicament for treating rheumatism and rheumatoid disease, and preparing method thereof
08/24/2011	CN101485876B Preparation method of Chinese medicine emplastrum for expelling rheumatism and relieving pain
08/24/2011	CN101485799B Paste capable of dispelling pain and eliminating cancer
08/24/2011	CN101472580B Therapeutic or prophylactic agent for allergic dermatitis
08/24/2011	CN101415685B Kinase inhibitors and methods of use thereof
08/24/2011	CN101375954B Medicament composition, preparation method thereof and use

1 ... 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 ... 1272